U.S. markets closed
  • S&P 500

    4,429.10
    +26.44 (+0.60%)
     
  • Dow 30

    35,064.25
    +271.58 (+0.78%)
     
  • Nasdaq

    14,895.12
    +114.58 (+0.78%)
     
  • Russell 2000

    2,236.01
    +39.69 (+1.81%)
     
  • Crude Oil

    69.10
    +0.01 (+0.01%)
     
  • Gold

    1,805.90
    -3.00 (-0.17%)
     
  • Silver

    25.17
    -0.12 (-0.46%)
     
  • EUR/USD

    1.1839
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.2170
    +0.0330 (+2.79%)
     
  • GBP/USD

    1.3931
    -0.0000 (-0.00%)
     
  • USD/JPY

    109.7600
    +0.0070 (+0.01%)
     
  • BTC-USD

    41,022.19
    +1,180.27 (+2.96%)
     
  • CMC Crypto 200

    1,005.54
    +29.64 (+3.04%)
     
  • FTSE 100

    7,120.43
    -3.43 (-0.05%)
     
  • Nikkei 225

    27,728.12
    +144.04 (+0.52%)
     

The Polarean Imaging (LON:POLX) Share Price Has Soared 437%, Delighting Many Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

It might be of some concern to shareholders to see the Polarean Imaging plc (LON:POLX) share price down 11% in the last month. But that doesn't displace its brilliant performance over three years. Indeed, the share price is up a whopping 437% in that time. So the recent fall doesn't do much to dampen our respect for the business. The thing to consider is whether there is still too much elation around the company's prospects.

See our latest analysis for Polarean Imaging

Because Polarean Imaging made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

Polarean Imaging actually saw its revenue drop by 0.8% per year over three years. This is in stark contrast to the strong share price growth of 75%, compound, per year. There can be no doubt this kind of decoupling of revenue growth and share price growth is unusual to see in loss making companies. So there is a serious possibility that some holders are counting their chickens before they hatch.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Polarean Imaging stock, you should check out this free report showing analyst profit forecasts.

A Different Perspective

It's nice to see that Polarean Imaging shareholders have gained 167% (in total) over the last year. That gain actually surpasses the 75% TSR it generated (per year) over three years. The improving returns to shareholders suggests the stock is becoming more popular with time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 4 warning signs for Polarean Imaging (of which 2 don't sit too well with us!) you should know about.

Polarean Imaging is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.